Himchandana Atluri, MD, details factors to consider ahead of TKI selection in patients with chronic myeloid leukemia.
Himachandana Atluri, MD
Advertisement
Himachandana Atluri, MD, is an assistant professor of medicine (Hematology and Oncology) at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois.
Articles by Himachandana Atluri, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves SimpleScreen CRC Blood-Based Screening Test for Average-Risk Adults
2
Sonesitatug Vedotin Improves Overall Survival in Second- and Later-Line CLDN18.2-Positive Gastric/GEJ Cancer
3
Dr Le on Choosing Between Zongertinib and Sevabertinib in HER2 TKD–Mutant NSCLC
4
Innovative Screening Approaches, Targeted Therapies, and Team-Based Care Drive Head and Neck Oncology Advances
5